Tranexamic acid reduces blood loss in corrective surgery for adolescent idiopathic scoliosis .
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2019;7(5):27 J Bone Joint Surg Am. 2018 Dec 5;100(23):2024-2032120 patients, 10-18 years of age, scheduled for corrective instrumented posterior fusion for adolescent scoliosis were randomized to either intravenous tranexamic acid or placebo. Patients were assessed for blood loss parameters intraoperatively and over the first 24 hours postoperatively. Results demonstrated a significantly lower rate of clinically relevant blood loss, defined as >20mL/kg, in the TXA group compared to the placebo group. In addition, intraoperative blood loss, intraoperative cell salvage volume, postoperative drain volume, and incidence of transfusion were significantly lower in the TXA group compared to the placebo group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
